Evidence map›Paper›PMID 30396894›Full record

ArticleInfection and immunity2019

Probiotic Exopolysaccharide Protects against Systemic

Wonbeom Paik, Francis Alonzo, Katherine L Knight

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Interaction BetweenCurrent pharmaceutical biotechnology · 2026
    Review
  2. ProbioticFoods (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Exopolysaccharides ofInternational journal of molecular sciences · 2022
    Article
  9. Review
  10. Probiotics Bring New Hope for Atherosclerosis Prevention and Treatment.Oxidative medicine and cellular longevity · 2022
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wonbeom PaikDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.
Francis AlonzoDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.
Katherine L KnightDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA kknight@luc.edu.
Loyola University Chicago · US

Funding

Staphylococcus aureus Survival During Nutrient Restriction and Suppression of Host Immunity.R01AI120994 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Francis Alonzo · 2016 to 2026
$4.6M
Experimental Immunology Training GrantT32AI007508 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI KNIGHT, KATHERINE L. · 1997 to 2022
$4.0M
Commensal Exopolysaccharide Protection from InflammationR01AI110586 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI KNIGHT, KATHERINE L. · 2015 to 2019
$1.9M
NIAID NIH HHS R01 AI110586NIAID NIH HHS R01 AI120994NIAID NIH HHS T32 AI007508
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsDisease Models, AnimalFemaleImmunologic FactorsInflammationMacrophagesMaleMice, Inbred C57BLPolysaccharides, BacterialProbioticsStaphylococcal InfectionsStaphylococcus aureusSurvival AnalysisTreatment Outcomeexopolysaccharide, BacillusImmunologic FactorsPolysaccharides, BacterialinflammationmacrophagesprobioticsS. aureus

Identifiers

PMID30396894
PMCPMC6300633
OpenAlexW2899170488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.